Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.30 |
| ▸ | MPI | P34949 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7113425 | 0.85 | LMNA (0.32) | LMNAL3MBTL1TDP1 | |
| SCHEMBL20296908 | 0.79 | LMNA (0.36) | LMNAL3MBTL1TDP1AKR1B1MPI | |
| SCHEMBL27929650 | 0.79 | LMNA (0.36) | LMNAL3MBTL1TDP1AKR1B1MPI | |
| SCHEMBL20296909 | 0.79 | LMNA (0.36) | LMNAL3MBTL1TDP1AKR1B1MPI | |
| SCHEMBL9814283 | 0.79 | LMNA (0.36) | LMNAL3MBTL1TDP1AKR1B1MPI | |
| SCHEMBL9476109 | 0.79 | LMNA (0.36) | LMNAL3MBTL1TDP1AKR1B1MPI | |
| SCHEMBL2559259 | 0.79 | LMNA (0.36) | LMNAL3MBTL1TDP1AKR1B1 | |
| SCHEMBL16447628 | 0.79 | LMNA (0.36) | LMNAL3MBTL1TDP1AKR1B1 | |
| SCHEMBL28602862 | 0.79 | LMNA (0.36) | LMNAL3MBTL1TDP1AKR1B1 | |
| Xylose SCHEMBL16447627 | 0.79 | CA1 (0.36) | LMNAL3MBTL1TDP1AKR1B1MPI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2003062298-A1 | CO-POLY(ESTER AMIDE) AND CO-POLY(ESTER URETHANE) COMPOSITIONS WHICH EXHIBIT BIODEGRADABILITY, METHODS FOR MAKING SAME AND USES FOR SAME | POLYRAVA LLC (US) | 2003-07-31 | — | — | WO | disclosed |
| EP-0811011-B1 | CARBOHYDRATE CONJUGATED BIO-ACTIVE COMPOUNDS | ICN PHARMACEUTICALS (US) | 2003-07-23 | — | — | EP | disclosed |